0001610717-23-000053.txt : 20230519
0001610717-23-000053.hdr.sgml : 20230519
20230519170258
ACCESSION NUMBER: 0001610717-23-000053
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230517
FILED AS OF DATE: 20230519
DATE AS OF CHANGE: 20230519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROBERTS BRYAN E
CENTRAL INDEX KEY: 0001239242
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39035
FILM NUMBER: 23941320
MAIL ADDRESS:
STREET 1: C/O VENROCK ASSOCIATES
STREET 2: 2494 SAND HILL ROAD STE 200
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 10x Genomics, Inc.
CENTRAL INDEX KEY: 0001770787
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 455614458
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: (925) 401-7300
MAIL ADDRESS:
STREET 1: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: 10X Genomics, Inc.
DATE OF NAME CHANGE: 20190315
4
1
form4.xml
X0407
4
2023-05-17
0001770787
10x Genomics, Inc.
TXG
0001239242
ROBERTS BRYAN E
C/O 10X GENOMICS, INC.
6230 STONERIDGE MALL ROAD
PLEASANTON
CA
94588
true
false
Class A Common Stock
2023-05-17
4
C
0
3790422
0
A
3790422
I
By Funds
Class A Common Stock
411205
I
By Trusts
Class A Common Stock
86638
D
Class B Common Stock
2023-05-17
4
C
0
3790422
0
D
Class A Common Stock
3790422
0
I
By Funds
Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation.
On May 10, 2023, Venrock Associates VI, L.P. ("VA VI") and Venrock Partners VI, L.P. ("VP VI") distributed an aggregate of 1,037,825 shares of Class A Common Stock to their limited partners and general partners. Of the 1,037,825 shares distributed, 962,309 shares were distributed by VA VI to its general partner, Venrock Management VI, LLC ("VM VI") and 75,516 shares were distributed by VP VI to its general partner, Venrock Partners Management VI, LLC ("VPM VI").
Represents (a) 3,514,480 shares of Class A common stock held by VA VI and (b) 275,942 shares of Class A common stock held by VP VI. VM VI is the sole general partner of VA VI. VPM VI is the sole general partner of VP VI. The Reporting Person is a member of VM VI and VPM VI and disclaims beneficial ownership over all shares held by VA VI and VP VI, except to the extent of his indirect pecuniary interests therein.
These shares are held by trusts for the benefit of the Reporting Person and his family members.
On May 12, 2023, the Reporting Person received an aggregate of 83,893 shares of Class A Common Stock as part of the distribution of shares of VM VI and VPM VI.
Represents (a) 83,893 shares of Class A common stock held directly by the Reporting Person and (b) 2,745 shares of Class A common stock held on behalf of VR Management, LLC (the "Management Company"). The Reporting Person is a member of the Management Company. Under an agreement between the Reporting Person and the Management Company, the Reporting Person is deemed to hold the reported shares for the sole benefit of the Management Company and must exercise the reported shares solely upon the direction of the Management Company, which is entitled to the shares. The Management Company may be deemed the indirect beneficial owner of the reported shares, and the Reporting Person may be deemed the indirect beneficial owner of the reported shares through his interest in the Management Company. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.
Represents (a) 0 shares of Class B common stock held by VA VI and (b) 0 shares of Class B common stock held by VP VI. VM VI is the sole general partner of VA VI. VPM VI is the sole general partner of VP VI. Dr. Roberts is a member of VM VI and VPM VI and disclaims beneficial ownership over all shares held by VA VI and VP VI, except to the extent of his indirect pecuniary interests therein.
/s/ Bryan E. Roberts
2023-05-19